Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians

BACKGROUND: The Middle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging respiratory pathogen with a high mortality rate and no specific treatments available to date. The purpose of this study was to determine the feasibility of conducting a randomized controlled trial (RCT) of convale...

Descripción completa

Detalles Bibliográficos
Autores principales: Arabi, Yaseen M., Al-Enezi, Farhan, Longuere, Kajsa-Stina, Balkhy, Hanan H., Al-Sultan, Mohamed, Al-Omari, Awad, Al-Hameed, Fahad M., Carson, Gail, Shindo, Nahoko, Fowler, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942900/
https://www.ncbi.nlm.nih.gov/pubmed/27405596
http://dx.doi.org/10.1186/s12871-016-0198-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942900/
https://www.ncbi.nlm.nih.gov/pubmed/27405596
http://dx.doi.org/10.1186/s12871-016-0198-x

Ejemplares similares